| The effect of hypoxia on mesenchymal stem cell biology M Ejtehadifar, K Shamsasenjan, A Movassaghpour, P Akbarzadehlaleh, ... Advanced pharmaceutical bulletin 5 (2), 141, 2015 | 225 | 2015 |
| Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment Y Yaghoubi, AA Movassaghpour, M Zamani, M Talebi, A Mehdizadeh, ... Life sciences 233, 116733, 2019 | 176 | 2019 |
| Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles: A novel therapeutic paradigm H Abbaszadeh, F Ghorbani, M Derakhshani, A Movassaghpour, ... Journal of cellular physiology 235 (2), 706-717, 2020 | 128 | 2020 |
| Implications of mesenchymal stem cells in regenerative medicine S Kariminekoo, A Movassaghpour, A Rahimzadeh, M Talebi, ... Artificial cells, nanomedicine, and biotechnology 44 (3), 749-757, 2016 | 121 | 2016 |
| The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells M Akbarzadeh, AA Movassaghpour, H Ghanbari, M Kheirandish, ... Scientific reports 7 (1), 17062, 2017 | 118 | 2017 |
| Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy P Lotfinegad, A Movassaghpour, J Majidi, B Baradaran Advanced pharmaceutical bulletin 4 (1), 5, 2014 | 82 | 2014 |
| Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells Z Davoudi, A Akbarzadeh, M Rahmatiyamchi, AA Movassaghpour, ... Asian Pacific journal of cancer prevention 15 (10), 4353-4358, 2014 | 76 | 2014 |
| Mesenchymal stem cells: new aspect in cell-based regenerative therapy M Mohammadian, K Shamsasenjan, PL Nezhad, M Talebi, M Jahedi, ... Advanced pharmaceutical bulletin 3 (2), 433, 2013 | 71 | 2013 |
| Regenerative potential of Wharton's jelly‐derived mesenchymal stem cells: A new horizon of stem cell therapy H Abbaszadeh, F Ghorbani, M Derakhshani, AA Movassaghpour, ... Journal of Cellular Physiology 235 (12), 9230-9240, 2020 | 62 | 2020 |
| Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use? M Zamani, Y Yaghoubi, A Movassaghpour, K Shakouri, A Mehdizadeh, ... Journal of cellular physiology 234 (10), 17172-17186, 2019 | 61 | 2019 |
| Modulatory role of exopolysaccharides of Kluyveromyces marxianus and Pichia kudriavzevii as probiotic yeasts from dairy products in human colon cancer cells YR Saadat, AY Khosroushahi, AA Movassaghpour, M Talebi, BP Gargari Journal of Functional Foods 64, 103675, 2020 | 59 | 2020 |
| The role of CD44 in cancer chemoresistance: A concise review Z Yaghobi, A Movassaghpour, M Talebi, MA Shadbad, ... European journal of pharmacology 903, 174147, 2021 | 57 | 2021 |
| Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells B Delalat, AA Pourfathollah, M Soleimani, H Mozdarani, SR Ghaemi, ... Hematology 14 (3), 125-132, 2009 | 55 | 2009 |
| Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system A Rahimzadeh, FS Tabatabaei Mirakabad, A Movassaghpour, ... Artificial cells, nanomedicine, and biotechnology 44 (2), 559-570, 2016 | 48 | 2016 |
| Endothelial cells' biophysical, biochemical, and chromosomal aberrancies in high‐glucose condition within the diabetic range A Rezabakhsh, E Nabat, M Yousefi, S Montazersaheb, O Cheraghi, ... Cell biochemistry and function 35 (2), 83-97, 2017 | 45 | 2017 |
| Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL A Hassanzadeh, M Farshdousti Hagh, MR Alivand, AAM Akbari, ... Journal of cellular physiology 233 (10), 6470-6485, 2018 | 43 | 2018 |
| The pro-Inflammatory cytokines effects on mobilization, self-renewal and differentiation of hematopoietic stem cells B Jahandideh, M Derakhshani, H Abbaszadeh, AA Movassaghpour, ... Human Immunology 81 (5), 206-217, 2020 | 42 | 2020 |
| The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia R Saraei, M Soleimani, AAM Akbari, MF Hagh, A Hassanzadeh, S Solali Biomedicine & Pharmacotherapy 107, 1010-1019, 2018 | 41 | 2018 |
| Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: non randomized, open-label clinical trial M Ahmadi, M Nouri, Z Babaloo, L Farzadi, A Ghasemzadeh, K Hamdi, ... Immunology letters 192, 12-19, 2017 | 41 | 2017 |
| Vitamin D-loaded nanostructured lipid carrier (NLC): a new strategy for enhancing efficacy of doxorubicin in breast cancer treatment M Sabzichi, J Mohammadian, M Mohammadi, F Jahanfar, ... Nutrition and cancer 69 (6), 840-848, 2017 | 39 | 2017 |
Mehdi TalebiPhD. in Cell Therapy (Applied Cell Sciences), Msc. in Hematology and Blood Banking, TabrizBestätigte E-Mail-Adresse bei tbzmed.ac.ir
